GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Ending Cash Position

Yili Chuannig Biotechnology Co (SZSE:301301) Ending Cash Position : ¥883 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Ending Cash Position?

Yili Chuannig Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥883 Mil.

Yili Chuannig Biotechnology Co's quarterly Ending Cash Position declined from Sep. 2023 (¥1,029 Mil) to Dec. 2023 (¥758 Mil) but then increased from Dec. 2023 (¥758 Mil) to Mar. 2024 (¥883 Mil).

Yili Chuannig Biotechnology Co's annual Ending Cash Position increased from Dec. 2021 (¥507 Mil) to Dec. 2022 (¥1,624 Mil) but then declined from Dec. 2022 (¥1,624 Mil) to Dec. 2023 (¥758 Mil).

Yili Chuannig Biotechnology Co Ending Cash Position Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Ending Cash Position Chart

Yili Chuannig Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 168.89 507.42 506.66 1,624.12 758.01

Yili Chuannig Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,023.53 1,106.67 1,029.20 758.01 883.12

Yili Chuannig Biotechnology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Yili Chuannig Biotechnology Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1624.124+-866.11
=758

Yili Chuannig Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=758.014+125.108
=883

Yili Chuannig Biotechnology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Ending Cash Position
Comparable Companies
SHSE:688520 SZSE:301207 SZSE:300009 SHSE:688278 SZSE:000403 SHSE:688578 SHSE:688166 SHSE:688639 SHSE:688177 SZSE:300294 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000
Website
http://www.klcnsw.com
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines